The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction

FASEB Journal

Volumn 21, Issue 13, 2007, Pages 3592-3605

  Evseenko, Denis A ^a   Murthi, Padma ^d,e   Paxton, James W ^b   Reid, Glen ^c   Emerald, B Starling ^a   Mohankumar, K M ^a   Lobie, Peter E ^a   Brennecke, Shaun P ^d,e   Kalionis, Bill ^d,e   Keelan, J A ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Genesis Research & Development Corporation Ltd   (New Zealand)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer resistance protein; Ceramide; Cytokines

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CERAMIDE; CYTOKINE; GAMMA INTERFERON; PHOSPHATIDYLSERINE; PROTOPORPHYRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; TROPHOBLAST;

APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CERAMIDES; DNA PRIMERS; FEMALE; FETAL GROWTH RETARDATION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NEOPLASM PROTEINS; PLACENTA; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 35948966011     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8688com     Document Type: Article

References (51)

1. Haimeur, A., Conseil, G., Deeley, R. G., and Cole, S. P. (2004) The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug. Metab. 5, 21-53
2. Allikmets, R., L.M., S., Hutchinson, A., Romano-Spica, V., and Dean, M. (1998) A human placenta-specific ATP-binding cassete gene on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58, 5337-5339
3. Jonker, J. W., Freeman, J., Bolscher, E., Musters, S., Alvi, A. J., Titley, I., Schinkel, A. H., and Dale, T. C. (2006) Contribution of the ABC Transporters Bcrp1 and Mdr1a/1b to the Side Population Phenotype in Mammary Gland and Bone Marrow of Mice. Stem. Cells 23, 1059-1065
4. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 95, 15665-15670
5. Woehlecke, H., Pohl, A., Alder-Baerens, N., Lage, H., and Herrmann, A. (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem. J. 376, 489-495
6. Choudhuri, S., and Klaassen, C. D. (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25, 231-259
7. Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., and Schuetz, J. D. (2004) The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218-24225
8. Johnstone, R. W., Cretney, E., and Smyth, M. J. (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93, 1075-1085
9. Pallis, M., and Russell, N. (2000) P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. Blood 95, 2897-2904
10. Paumi, C., Wright, M., Alan, J., Townsend, A., and Morrow, C. (2003) Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Biochemistry 42, 5429-5437
11. Jonker, J. W., Smit, J. W., Brinkhuis, M., Maliepaard, M., Beijnen, J., Schellens, J. H., and Schinkel, A. (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer. Inst. 92, 1651-1656
12. Ceckova, M., Libra, A., Pavek, P., Nachtigal, P., Brabec, M., Fuchs, R., and Staud, F. (2006) Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin. Exp. Pharmacol. Physiol. 33, 58-65
13. Evseenko, D. A., Paxton, J. W., and Keelan, J. A. (2006) ABC drug transporter expression and functional activity in tropho-blast-like cell lines and differentiating primary trophoblast. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1357-R1365
14. Evseenko, D. A., Paxton, J. W., and Keelan, J. A. (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids and growth factors. Drug Metab. Dispos. 35, 595-601
15. Jonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., and Schinkel, A. H. (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11, 127-129
16. Abbott, B. L. (2006) ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells. Clin. Advan. Hematol. Oncol. 4, 63-72
17. Bakketeig, L. S., Butte, N., de Onis, M., Kramer, M., O'Donnell, A., Prada, J. A., and Hoffman, H. J. (1998) Report of the IDECG Working Group on definitions, classifications, causes, mechanisms and prevention of IUGR. Eur. J. Clin. Nutr. 52, S94-96
18. Bamberg, C., and Kalache, K. D. (2004) Prenatal diagnosis of fetal growth restriction. Fetal Neonatal Med. 9, 387-394
19. Wollmann, H. A. (1998) Intrauterine growth restriction: definition and etiology. Horm. Res. 49, 1-6
20. Brodsky, D., and Christou, H. (2004) Current concepts in intrauterine growth restriction. J. Intensive Care. Med. 19, 307-319
21. Kingdom, J., Huppertz, B., Seaward, G., and Kaufmann, P. (2000) Development of the placental villous tree and its consequences for fetal growth. Eur. J. Obstet. Gynecol. Reprod. 92, 35-43
22. Ghidini, A. (1996) Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet. Gynecol. Surv. 51, 376-382
23. Gagnon, R. (2003) Placental insufficiency and its consequences. Eur. J. Obstet. Gynecol. Reprod. Biol. 110, S99-107
24. Mayhew, T. M., Wijesekara, J., Baker, P. N., and Ong, S. S. (2004) Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta 25, 829-833
25. Sanchez-Vera, I., Bonet, B. M., Quintanar, A., and Lopez-Salva, A. (2005) Increased low-density lipoprotein susceptibility to oxidation in pregnancies and fetal growth restriction. Obstet. Gynecol. Surv. 106, 345-351
26. Chaddha, V., Viero, S., Huppertz, B., and Kingdom, J. (2004) Developmental biology of the placenta and the origins of placental insufficiency. Semin. Fetal Neonatal Med. 9, 357-369
27. Holcberg, G., Huleihel, M., Sapir, O., Katz, M., Tsadkin, M., Furman, B., Mazor, M., and Myatt, L. (2001) Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentas. Eur. J. Obstet. Gynecol. Reprod. 94, 69-72
28. Payne, S. G., Brindley, D. N., and Guilbert, L. J. (1999) Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. J. Cell. Physiol. 180, 263-270
29. Straszewski-Chavez, S. L., Abrahams, V. M., and Mor, G. (2005) The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr. Rev. 26, 877-897
30. Hannun, Y. A., and Luberto, C. (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol. 10, 73-80
31. Guaran, R. L., Wein, P., Sheedy, M., Walstab, J., and Beischer, N. A. (1994) Update of growth percentiles for infants born in an Australian population. Aust. N. Z. J. Obstet. Gynaecol. 34, 39-50
32. Blumenstein, M., Mitchell, M. D., Groome, N. P., and Keelan, J. A. (2002) Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta 23, 735-741
33. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034
34. Black, S., Kadyrov, M., Kaufmann, P., Ugele, B., Emans, N., and Huppertz, B. (2004) Syncytial fusion of human trophoblast depends on caspase 8. Cell Death Differ. 11, 90-98
35. Otake, M., Nishiwaki, M., Kobayashi, Y., Baba, S., Kohno, E., Kawasaki, T., Fujise, Y., and Nakamura, H. (2003) Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma. Br. J. Cancer 89, 730-736
36. Sullards, M. C., and Merrill, A. H., Jr. (2001) Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE 67, PL1
37. Johnstone, E. D., Mackova, M., Das, S., Payne, S. G., Lowen, B., Sibley, C. P., Chan, G., and Guilbert, L. J. (2005) Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta 26, 548-555
38. Morrish, D. W., Dakour, J., and Li, H. (1998) Functional regulation of human trophoblast differentiation. J. Reprod. Immunol. 39, 179-195
39. Dumitru, C. A., and Gulbins, E. (2006) TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 25, 5612-5625
40. Gentil, B., Grimot, F., and Riva, C. (2003) Commitment to apoptosis by ceramides depends on mitochondrial respiratory function, cytochrome c release and caspase-3 activation in Hep-G2 cells. Mol. Cell. Biochem. 254, 203-210
41. Van Meer, G., Halter, D., Sprong, H., Somerharju, P., and Egmond, M. R. (2006) ABC lipid transporters: extruders, flippases, or flopless activators? FEBS Lett. 580, 1171-1177
42. Hojjati, M. R., Li, Z., Zhou, H., Tang, S., Huan, C., Ooi, E., Lu, S., and Jiang, X. C. (2005) Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J. Biol. Chem. 280, 10284-10289
43. Ghering, A. B., and Davidson, W. S. (2006) Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. J. Lipid Res. 47, 2781-2788
44. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., and Green, D. R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exper. Med. 182, 1545-1556
45. Daleke, D. L. (2003) Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res. 44, 233-242
46. Evseenko, D. A., Paxton, J. W., and Keelan, J. A. (2007) The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast like BeWo cells. Placenta Suppl. A, S116-S120
47. Myatt, L. (2006) Placental adaptive responses and fetal programming. J. Physiol. 572, 25-30
48. Kingdom, J. C., and Kaufmann, P. (1997) Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18, 613-621
49. Bartha, J. L., Romero-Carmona, R., and Comino-Delgado, R. (2003) Inflammatory cytokines in intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 82, 1099-1102
50. Kilani, R. T., Mackova, M., Davidge, S. T., Winkler-Lowen, B., Demianczuk, N., and Guilbert, L. J. (2007) Endogenous tumor necrosis factor {alpha} mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentas. Reproduction 133
51. Laskowska, M., Leszczyska-Gorzelak, B., Laskowska, K., and Oleszczuk, J. (2006) Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus. J. Matern. Fetal Neonatal. Med. 19, 347-251